Osteoporosis

QS scientists have good experience supporting critical decisions in drug development in osteoporosis. We have built an Osteoporosis Clinical Outcomes Database to help facilitate model-based meta-analysis in this disease area. Analysis on the database can help answer important questions, such as:

What is the relationship between bone mineral density and fracture risk?
Is this relationship similar across mechanisms of action?
Does this relationship explain all treatment effect or is there an additional benefit of certain treatments?
What anatomical site of BMD changes is most predictive for fracture risk? Is there a plateau on the benefit for fracture risk?